ZTS
Zoetis Inc.
Drug Manufacturers - Specialty & Generic · Healthcare · United States
75.84
close · 2026-08-13
value
47
cheaper than peers47
quality
66
stronger fundamentals66
ranked against
Drug Manufacturers - Specialty & Generic
value
quality
34 peerswide variation
Value inputs
| measure | company | vs peers |
| EV to EBITDA | 9.25× | 71 |
| forward P/E | 11.26× | 57 |
| price to sales | 3.25× | 40 |
| price to book | 9.67× | 29 |
4 of 12 measures available
Quality inputs
| measure | company | vs peers |
| return on equity | 64.9% | 95 |
| operating margin | 40.7% | 90 |
| revenue growth | -0.2% | 27 |
| debt to equity | 294.0% | 22 |
4 of 4 measures available
Facts
| market cap | $31B |
| free cash flow | $2.02B |
| employees | 14,500 |
| first trade | 2013-02-01 |
| next earnings | 2026-08-06 |
| fundamentals updated | 2026-08-10 |